CD21 (Dendritic Cell) by Immunohistochemistry
Also known as: CD21 IHC
Use
CD21 (Dendritic Cell) by Immunohistochemistry is used to evaluate the presence of dendritic cells in tissue samples. This test can help in the diagnosis and classification of certain types of lymphomas and other lymphoproliferative disorders where dendritic cell presence is a factor. Immunohistochemistry staining results can provide valuable insights into cell type, lineage, and immune profiling, which are critical in forming an accurate diagnosis.
Special Instructions
Not provided.
Limitations
The immunohistochemistry staining process is performed as a stain and return service. It provides technical staining only, and interpretation must be carried out by a qualified pathologist. Improper specimen handling or depleted specimens can lead to compromised results. Additionally, non-representative tissue types submitted may result in rejections or conduct of further testing, which could delay diagnostic processes.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
CD21
Protein
LOINC Codes
- 94736-6 - Tissue block ID Spec
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
2 slides
Container
Tissue transport kit (ARUP supply #47808)
Collection Instructions
Formalin fix (10 percent neutral buffered formalin) and paraffin embed specimen (cells must be prepared into a cellblock). Transport tissue block or 5 unstained (3- to 5-micron thick sections), positively charged slides in a tissue transport kit. Protect from excessive heat.
Storage Instructions
Room temperature or refrigerated. Ship in cooled container during summer months.
Causes for Rejection
Depleted specimens. Specimens submitted with non-representative tissue type.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant